New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
16:39 EDTCRM, VVUS, AET, SQNM, ZLC, TLYS, STJOn The Fly: Closing Wrap
Stocks on Wall Street were higher on the day, the last full trading session of the week ahead of Thursday's holiday and Friday's half day. Jobless data that was in-line with expectations did little to move the markets before the open, but the markets slowly moved higher through the session, although volume remained light. Just after midday, news crossed that a cease fire between Israel and Hamas had been reached, tempering fears that the conflict could escalate to involve other players in the region and have broader economic impacts... ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 410,000, which was in-line with forecasts. Markit's "flash" November flash PMI rose to 52.4 from 51.0 in October. The final November reading of the University of Michigan Sentiment index slipped to 82.7 from its 84.9 preliminary reading. The leading indicators edged up 0.2% in October to 96.0 from 95.8 in September. In Europe, the region's finance ministers and the IMF were unable to reach a bailout agreement for Greece and will meet again on Monday with an eye on resolving the remaining disagreements. In Asia, Japanese exports fell 6.5% in October, lower than expectations for a 4.9% decline... COMPANY NEWS: Salesforce.com's (CRM) Q3 results beat on the top and bottom lines and RW Baird and Wells Fargo reiterated their Outperform ratings on the stock following the report, and shares of Salesforce.com traded higher on the session, settling up $12.88, or 8.83%, to $158.78... MAJOR MOVERS: Among notable gainers were shares of VIVUS (VVUS), up $1.38, or 13.33%, to $11.73 after Aetna (AET) posted a policy revision that expands coverage of the company's weight-loss drug Qsymia. Also higher were shares of Sequenom (SQNM), up 56c, or 15.18%, to $4.25 after a committee of the American College of Obstetricians and Gynecologists recommended that cell-free fetal DNA testing be offered to certain at-risk patients. Among the noteworthy were shares of Zale (ZLC), down over $2.23, or 29.97%, to $5.21, and Tilly's (TLYS), down $2.69, or 17.18%, to $12.97 after reporting earnings. Also lower were shares of St. Jude Medical (STJ), which fell $4.34, or 12.15%,to $31.37 after an FDA inspection report cited serious flaws in its oversight of design changes in its Durata line of defibrillator leads... INDICES The Dow was up 48.38, or 0.38%, to 12,836.89; the S&P 500 was up 3.22, or 0.23%, to 1,391.03;the Nasdaq was up 9.87, or 0.34%, to 2,926.55.
News For CRM;VVUS;AET;SQNM;ZLC;TLYS;STJ From The Last 14 Days
Check below for free stories on CRM;VVUS;AET;SQNM;ZLC;TLYS;STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 22, 2014
07:59 EDTCRMSalesforce.com price target raised to $76 from $73 at UBS
Subscribe for More Information
07:48 EDTCRMSalesforce.com reported strong Q2 results, says Oppenheimer
After Salesforce.com reported stronger than expected Q2 results, Oppenheimer thinks the company's guidance for the remainder of the year can still rise further. The firm believes that the company's success in marketing and platform products could enable its revenue to beat expectations going forward. It keeps a $71 price target and Outperform rating on the shares.
07:06 EDTCRMSalesforce.com price target raised to $70 from $65 at Deutsche Bank
Subscribe for More Information
06:20 EDTCRMOptions expected to be active
Options expected to be active: GME ARO CRM INTU TFM MRVL ROST BRCD
August 21, 2014
18:22 EDTCRMOn The Fly: After Hours Movers
Subscribe for More Information
18:22 EDTCRMSalesforce.com CEO: Microsoft the number one customer of ExactTarget
Says Europe performing beyond expectations. Marc Benioff is speaking on CNBC.
18:01 EDTCRMSalesforce.com targets $1.1B in cash flow at end of FY15
Subscribe for More Information
16:09 EDTCRMSalesforce.com reports Q2 operating cash flow $246M, up 34% YoY
Subscribe for More Information
16:08 EDTCRMSalesforce.com raises FY15 adjusted EPS view to 50c-52c from 49c-51c
Subscribe for More Information
16:06 EDTCRMSalesforce.com sees Q3 adjusted EPS 12c-13c, consensus 13c
Subscribe for More Information
16:05 EDTCRMSalesforce.com reports Q2 adjusted EPS 13c, consensus 12c
Subscribe for More Information
15:15 EDTCRMNotable companies reporting after market close
Subscribe for More Information
13:45 EDTCRM Earnings Preview: Analysts positive on Salesforce.com ahead of Q2 earnings
Subscribe for More Information
13:40 EDTCRMSalesforce.com technical comments ahead of earnings
Subscribe for More Information
10:34 EDTCRMOptions Update; August 21, 2014
Subscribe for More Information
09:52 EDTCRMSalesforce.com August weekly 54.5 straddle priced for 5.9% move into Q2
Subscribe for More Information
August 20, 2014
08:17 EDTCRMSalesforce.com appears poised to report good Q2 results, says Oppenheimer
Subscribe for More Information
August 19, 2014
11:32 EDTSQNMLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
08:05 EDTCRMSalesforce.com Q2 results expected to be uneventful, says UBS
Subscribe for More Information
07:40 EDTCRMSalesforce.com August weekly volatility increases into Q2 and outlook
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use